{"id":"https://openalex.org/W2088760487","doi":"https://doi.org/10.1002/hup.907","title":"Influence of the tyrosine hydroxylase val81met polymorphism and catechol\u2010O\u2010methyltransferase val158met polymorphism on the antidepressant effect of milnacipran","display_name":"Influence of the tyrosine hydroxylase val81met polymorphism and catechol\u2010O\u2010methyltransferase val158met polymorphism on the antidepressant effect of milnacipran","alternate_titles":[],"publication_year":2007,"publication_date":"2007-11-20","ids":{"openalex":"https://openalex.org/W2088760487","doi":"https://doi.org/10.1002/hup.907","mag":"2088760487","pmid":"https://pubmed.ncbi.nlm.nih.gov/18023073"},"language":"en","primary_location":{"id":"doi:10.1002/hup.907","doi":"https://doi.org/10.1002/hup.907","is_oa":false,"landing_page_url":"https://doi.org/10.1002/hup.907","pdf_url":null,"source":{"id":"https://openalex.org/S154207414","display_name":"Human Psychopharmacology Clinical and Experimental","issn_l":"0885-6222","issn":["0885-6222","1099-1077"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human Psychopharmacology: Clinical and Experimental","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2088760487"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5105366073","display_name":"Keizo Yoshida","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I60134161","display_name":"Nagoya University","ror":"https://ror.org/04chrp450","country_code":"JP","type":"education","lineage":["https://openalex.org/I60134161"]}],"countries":["JP"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Keizo Yoshida","raw_affiliation_strings":["Department of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Japan. cxw01076@nifty.com","Department of Psychiatry , Nagoya University Graduate School of Medicine , Nagoya, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Japan. cxw01076@nifty.com","institution_ids":["https://openalex.org/I60134161"]},{"raw_affiliation_string":"Department of Psychiatry , Nagoya University Graduate School of Medicine , Nagoya, Japan","institution_ids":["https://openalex.org/I60134161"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5106022499","display_name":"Hisashi Higuchi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I163917720","display_name":"St. Marianna University School of Medicine","ror":"https://ror.org/043axf581","country_code":"JP","type":"education","lineage":["https://openalex.org/I163917720"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hisashi Higuchi","raw_affiliation_strings":["Department of Neuropsychiatry, St. Marianna University School of Medicine, Kanagawa, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neuropsychiatry, St. Marianna University School of Medicine, Kanagawa, Japan","institution_ids":["https://openalex.org/I163917720"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067901270","display_name":"Hitoshi Takahashi","orcid":"https://orcid.org/0009-0003-4103-0652","observed_orcids":["https://orcid.org/0009-0003-4103-0652"]},"institutions":[{"id":"https://openalex.org/I4210136522","display_name":"Tokyo Women's Medical University","ror":"https://ror.org/03kjjhe36","country_code":"JP","type":"education","lineage":["https://openalex.org/I4210136522"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hitoshi Takahashi","raw_affiliation_strings":["Department of Psychiatry, Tokyo Women's Medical University, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Tokyo Women's Medical University, Tokyo, Japan","institution_ids":["https://openalex.org/I4210136522"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004530058","display_name":"Mitsuhiro Kamata","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I112524849","display_name":"Yamagata University","ror":"https://ror.org/00xy44n04","country_code":"JP","type":"education","lineage":["https://openalex.org/I112524849"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mitsuhiro Kamata","raw_affiliation_strings":["Health Administration Center, Yamagata University, Yamagata, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Health Administration Center, Yamagata University, Yamagata, Japan","institution_ids":["https://openalex.org/I112524849"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082038216","display_name":"Kazuhiro Sato","orcid":"https://orcid.org/0000-0001-8818-5203","observed_orcids":["https://orcid.org/0000-0001-8818-5203"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kazuhiro Sato","raw_affiliation_strings":["Akita Kaiseikai Hospital, Akita, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Akita Kaiseikai Hospital, Akita, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103263844","display_name":"Kazuyuki Inoue","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210132405","display_name":"Akita University Hospital","ror":"https://ror.org/02szmmq82","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210132405"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kazuyuki Inoue","raw_affiliation_strings":["Department of Pharmaceutical Science, Akita University Hospital, Akita, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Science, Akita University Hospital, Akita, Japan","institution_ids":["https://openalex.org/I4210132405"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Toshio Suzuki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210132405","display_name":"Akita University Hospital","ror":"https://ror.org/02szmmq82","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210132405"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Toshio Suzuki","raw_affiliation_strings":["Department of Pharmaceutical Science, Akita University Hospital, Akita, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Science, Akita University Hospital, Akita, Japan","institution_ids":["https://openalex.org/I4210132405"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103087989","display_name":"Kunihiko Itoh","orcid":"https://orcid.org/0000-0003-4436-0529","observed_orcids":["https://orcid.org/0000-0003-4436-0529"]},"institutions":[{"id":"https://openalex.org/I1298590031","display_name":"Shizuoka University","ror":"https://ror.org/01w6wtk13","country_code":"JP","type":"education","lineage":["https://openalex.org/I1298590031"]},{"id":"https://openalex.org/I150240954","display_name":"University of Shizuoka","ror":"https://ror.org/04rvw0k47","country_code":"JP","type":"education","lineage":["https://openalex.org/I150240954"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kunihiko Itoh","raw_affiliation_strings":["Department of Clinical Pharmacology and Genetics, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology and Genetics, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan","institution_ids":["https://openalex.org/I1298590031","https://openalex.org/I150240954"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5026728831","display_name":"Norio Ozaki","orcid":"https://orcid.org/0000-0002-7360-4898","observed_orcids":["https://orcid.org/0000-0002-7360-4898"]},"institutions":[{"id":"https://openalex.org/I60134161","display_name":"Nagoya University","ror":"https://ror.org/04chrp450","country_code":"JP","type":"education","lineage":["https://openalex.org/I60134161"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Norio Ozaki","raw_affiliation_strings":["Department of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Japan","institution_ids":["https://openalex.org/I60134161"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5105366073"],"corresponding_institution_ids":["https://openalex.org/I60134161"],"apc_list":{"value":4030,"currency":"USD","value_usd":4030},"apc_paid":null,"fwci":4.2489,"has_fulltext":false,"cited_by_count":59,"citation_normalized_percentile":{"value":0.9333156,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"23","issue":"2","first_page":"121","last_page":"128"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.3978999853134155,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.3978999853134155,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.3109999895095825,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.24950000643730164,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/milnacipran","display_name":"milnacipran","score":0.9670000076293945},{"id":"https://openalex.org/keywords/tyrosine-hydroxylase","display_name":"tyrosine hydroxylase","score":0.8679999709129333},{"id":"https://openalex.org/keywords/catechol-o-methyltransferase","display_name":"catechol-O-methyltransferase","score":0.9990000128746033},{"id":"https://openalex.org/keywords/comt-val158met-polymorphism","display_name":"COMT Val158Met polymorphism","score":0.996999979019165},{"id":"https://openalex.org/keywords/antidepressant-response","display_name":"antidepressant response","score":0.7879999876022339},{"id":"https://openalex.org/keywords/major-depressive-disorder","display_name":"major depressive disorder","score":0.9319999814033508},{"id":"https://openalex.org/keywords/noradrenergic-pathways","display_name":"noradrenergic pathways","score":0.9070000052452087},{"id":"https://openalex.org/keywords/comt-genotype","display_name":"COMT genotype","score":0.6940000057220459},{"id":"https://openalex.org/keywords/serotonin-norepinephrine-reuptake-inhibitors","display_name":"serotonin-norepinephrine reuptake inhibitors","score":0.875},{"id":"https://openalex.org/keywords/pharmacogenetics","display_name":"pharmacogenetics","score":0.7509999871253967}],"concepts":[{"id":"https://openalex.org/C2780199185","wikidata":"https://www.wikidata.org/wiki/Q421058","display_name":"Milnacipran","level":4,"score":0.979196310043335},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.7702417373657227},{"id":"https://openalex.org/C185361966","wikidata":"https://www.wikidata.org/wiki/Q94291140","display_name":"Catechol-O-methyl transferase","level":4,"score":0.7416171431541443},{"id":"https://openalex.org/C149737253","wikidata":"https://www.wikidata.org/wiki/Q3240252","display_name":"Polymorphism (computer science)","level":4,"score":0.5724503993988037},{"id":"https://openalex.org/C2775951788","wikidata":"https://www.wikidata.org/wiki/Q418293","display_name":"Tryptophan hydroxylase","level":5,"score":0.5509851574897766},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.4534880518913269},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4377589523792267},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.41856902837753296},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4135613441467285},{"id":"https://openalex.org/C135763542","wikidata":"https://www.wikidata.org/wiki/Q106016","display_name":"Genotype","level":3,"score":0.3769668936729431},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3691978454589844},{"id":"https://openalex.org/C37000724","wikidata":"https://www.wikidata.org/wiki/Q50430226","display_name":"Serotonergic","level":4,"score":0.2548777163028717},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.20495164394378662},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0869256854057312},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.07697984576225281},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.05463981628417969},{"id":"https://openalex.org/C2781161787","wikidata":"https://www.wikidata.org/wiki/Q48360","display_name":"Hippocampus","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000078764","descriptor_name":"Milnacipran","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000483","descriptor_name":"Alleles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002394","descriptor_name":"Catechol O-Methyltransferase","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D002394","descriptor_name":"Catechol O-Methyltransferase","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003521","descriptor_name":"Cyclopropanes","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D003521","descriptor_name":"Cyclopropanes","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003865","descriptor_name":"Major Depressive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003865","descriptor_name":"Major Depressive Disorder","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005838","descriptor_name":"Genotype","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007564","descriptor_name":"Japan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011110","descriptor_name":"Polymorphism, Genetic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014446","descriptor_name":"Tyrosine 3-Monooxygenase","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D014446","descriptor_name":"Tyrosine 3-Monooxygenase","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016133","descriptor_name":"Polymerase Chain Reaction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D018759","descriptor_name":"Adrenergic Uptake Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018759","descriptor_name":"Adrenergic Uptake Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D044466","descriptor_name":"Asian People","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1002/hup.907","doi":"https://doi.org/10.1002/hup.907","is_oa":false,"landing_page_url":"https://doi.org/10.1002/hup.907","pdf_url":null,"source":{"id":"https://openalex.org/S154207414","display_name":"Human Psychopharmacology Clinical and Experimental","issn_l":"0885-6222","issn":["0885-6222","1099-1077"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human Psychopharmacology: Clinical and Experimental","raw_type":"journal-article"},{"id":"pmid:18023073","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18023073","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human psychopharmacology","raw_type":"Clinical Trial"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.590.4169","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.590.4169","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://www.utsu-rework.org/info/01Hum Psychopharmacol23_2 p121-8_2008-1.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":24,"referenced_works":["https://openalex.org/W76992962","https://openalex.org/W1780734727","https://openalex.org/W1867335213","https://openalex.org/W1970188324","https://openalex.org/W1973476131","https://openalex.org/W1979782032","https://openalex.org/W1982707873","https://openalex.org/W1996395058","https://openalex.org/W2018804190","https://openalex.org/W2030045599","https://openalex.org/W2031268952","https://openalex.org/W2077332064","https://openalex.org/W2077599443","https://openalex.org/W2086524734","https://openalex.org/W2088504456","https://openalex.org/W2100040984","https://openalex.org/W2128648721","https://openalex.org/W2131721815","https://openalex.org/W2131823335","https://openalex.org/W2137765991","https://openalex.org/W2416449544","https://openalex.org/W2441189667","https://openalex.org/W4233056103","https://openalex.org/W4301672277"],"related_works":["https://openalex.org/W2178990492","https://openalex.org/W1970188324","https://openalex.org/W2076620343","https://openalex.org/W2022431040","https://openalex.org/W98625413","https://openalex.org/W2506694340","https://openalex.org/W2699428545","https://openalex.org/W2091967472","https://openalex.org/W2477173160"],"abstract_inverted_index":{"OBJECTIVE:":[0],"Genetic":[1],"polymorphisms":[2,45],"of":[3,14,20,28,52,74,101,105,119,132,143,152,171],"the":[4,12,23,29,36,49,79,120,135,144,149,161,168],"noradrenergic":[5,24],"pathway":[6],"can":[7],"be":[8],"factors":[9],"to":[10,33,111],"predict":[11],"effect":[13,51,131,151,170],"antidepressants":[15],"when":[16],"their":[17],"pharmacological":[18],"mechanisms":[19],"action":[21],"include":[22],"system.":[25],"The":[26,103,116],"purpose":[27],"present":[30],"study":[31],"was":[32,76,109,124,154],"determine":[34,112],"whether":[35],"tyrosine":[37],"hydroxylase":[38],"(TH)":[39],"val81met":[40,146],"and":[41,81,93,98],"catechol-O-methyltransferase":[42],"(COMT)":[43],"val158met":[44,122,163],"are":[46],"associated":[47,125],"with":[48,62,68,78,126],"antidepressant":[50,150,169],"milnacipran,":[53],"a":[54,127],"serotonin/noradrenaline":[55],"reuptake":[56],"inhibitor.":[57],"METHOD:":[58],"Eighty-one":[59],"Japanese":[60],"patients":[61],"major":[63],"depressive":[64],"disorder":[65],"were":[66,88],"treated":[67],"milnacipran":[69,133,153],"for":[70],"6":[71,99],"weeks.":[72],"Severity":[73],"depression":[75],"assessed":[77],"Montgomery":[80],"Asberg":[82],"Depression":[83],"Rating":[84],"Scale":[85],"(MADRS).":[86],"Assessments":[87],"carried":[89],"out":[90],"at":[91,94],"baseline":[92],"1,":[95],"2,":[96],"4":[97],"weeks":[100],"treatment.":[102],"method":[104],"polymerase":[106],"chain":[107],"reaction":[108],"used":[110],"allelic":[113],"variants.":[114],"RESULTS:":[115],"met/met":[117],"genotype":[118],"COMT":[121,162],"polymorphism":[123,147,164],"significantly":[128],"faster":[129],"therapeutic":[130],"in":[134,165],"MADRS":[136],"score":[137],"during":[138],"this":[139],"study.":[140],"No":[141],"influence":[142],"TH":[145],"on":[148],"detected.":[155],"CONCLUSION:":[156],"These":[157],"results":[158],"suggest":[159],"that":[160],"part":[166],"determines":[167],"milnacipran.":[172]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2088760487","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2016-06-24T00:00:00"}
